Air Q Laryngeal Airway Versus the AmbuAura Gain as a Conduit for Endotracheal Intubation

NCT05607433 | Unknown

• 1 other identifier: supraglottic devices
• Study Type: interventional
• Target: 44
• Locations: 1 country
• Sites: 1

Brief Summary

The study aims to compare the efficacy of the Ambu AuraGain to that of the Air Q ILA as a conduit for endotracheal intubation assisted by tube exchanger. The comparison will be in terms of total intubation time, success rate of insertion of the tube exchanger as well as endotracheal intubation and complications.

Conditions

Difficult Intubation

Keywords

assisted intubation

Outcome Measures

Primary Outcomes (1)

• Total endotracheal intubation time

  tube exchanger intubation time plus endotracheal intubation time

  time of tube exchanger insertion and endotracheal tube insertion

Secondary Outcomes (2)

• success rate of endotracheal intubation

  1 second after insertion tube exchanger until successful endotracheal intubation

• Tube exchanger insertion time

  from disconnection of the supraglottic device from ventilator to successful insertion of tube exchanger in trachea

Other Outcomes (1)

• postoperative hoarseness of voice

  2 hours postoperative

Study Arms (2)

Air Q ILA group

EXPERIMENTAL

Air Q supraglottic device will be placed in the participants in this group .

Device: cook ®Airway Exchanger Catheter

Ambu AuraGain group

EXPERIMENTAL

Ambu AuraGain supraglottic device will be placed in the participants in this group .

Device: cook ®Airway Exchanger Catheter

Interventions

cook ®Airway Exchanger Catheter DEVICE

A tube exchanger is a small calibre , flexible tube used to guide endotracheal intubation through a supraglottic device.

Air Q ILA group; Ambu AuraGain group

Eligibility Criteria

• Age: 18 Years - 60 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• Age : 18 to 60
• ASA physical status 1 and 2
• body weight less than 90 kilos
• Ganzouri airway score less than or equal to 3.

You may not qualify if:

• Active respiratory or cardiac disease
• Any expected airway difficulties
• Craniofacial abnormalities or fractures
• patients with abnormal coagulation profile

Sponsors & Collaborators

• Cairo University: lead

Study Sites (1)

Kasr Alainy Hospital

Cairo, Elmanial, 11559, Egypt

Location

Related Publications (2)

• Karim YM, Swanson DE. Comparison of blind tracheal intubation through the intubating laryngeal mask airway (LMA Fastrach) and the Air-Q. Anaesthesia. 2011 Mar;66(3):185-90. doi: 10.1111/j.1365-2044.2011.06625.x.

  PMID: 21320087 BACKGROUND

• Bakker EJ, Valkenburg M, Galvin EM. Pilot study of the air-Q intubating laryngeal airway in clinical use. Anaesth Intensive Care. 2010 Mar;38(2):346-8. doi: 10.1177/0310057X1003800217.

  PMID: 20369770 BACKGROUND

Central Study Contacts

Hoda Alrify

CONTACT

002 01004226722; hodazakariasaleh@outlook.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Masking Details: only participants will be masked
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: assistant lecturer of anesthesia

Model Details: Randomized comparative study

Study Record Dates

• First Submitted: September 13, 2019
• First Posted: November 7, 2022
• Study Start: November 1, 2022
• Primary Completion: December 1, 2022
• Study Completion: December 1, 2022
• Last Updated: November 7, 2022

Record last verified: 2022-11

Locations

EG (1)